Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000113 · ClinicalTrials.gov registry record · Phase 3
Correction of Myopia Evaluation Trial (COMET)
A Phase 3 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 3
- Development phase
- 469
- Enrollment target
NCT00000113: Completed Phase 3 study, sponsored by Stony Brook University.
NCT00000113 is a Phase 3 study that has completed, run by Stony Brook University. The registered enrollment target is 469 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000113, a Phase 3 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 469 participants
- Enrollment target
Study Summary
To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography. To describe the natural history of juvenile-onset myopia in a group of children receiving conventional treatment (single vision lenses).
Interventions
- OTHER Progressive Addition Lenses
- OTHER single vision lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 469 participants |
| Start Date | 1997-09 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
What the finished NCT00000113 record still lists
NCT00000113 is an interventional study that assigns participants to a tested intervention. The registered 469 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 2 interventions - of which Progressive Addition Lenses is the first listed.
NCT00000113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000113 about?
NCT00000113 is a clinical study titled "Correction of Myopia Evaluation Trial (COMET)". To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography. To...
What is the current status of trial NCT00000113?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 469 participants. The study started on 1997-09. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00000113?
The interventions under investigation include: Progressive Addition Lenses (OTHER), single vision lenses (OTHER).
Who is sponsoring clinical trial NCT00000113?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000113's enrollment target sits among peer trials
469 815th of 2000 higher than 1,185 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia